Engineering Adhesion of the Probiotic Strain Escherichia coli Nissle to the Fungal Pathogen Candida albicans

Alexandre Chamas,Carl-Magnus Svensson,Carla Maneira,Marta Sporniak,Marc Thilo Figge,Gerald Lackner
DOI: https://doi.org/10.1021/acssynbio.4c00466
IF: 5.249
2024-09-14
ACS Synthetic Biology
Abstract:Engineering live biotherapeutic products against fungal pathogens such as Candida albicans has been suggested as a means to tackle the increasing threat of fungal infections and the development of resistance to classical antifungal treatments. One important challenge in the design of live therapeutics is to control their localization inside the human body. The specific binding capability to target organisms or tissues would greatly increase their effectiveness by increasing the local...
biochemical research methods
What problem does this paper attempt to address?